Changes in plasma arylsulfatase A level as a compensatory biomarker of early Parkinson’s disease

Lysosomal dysfunction has been associated with Parkinson’s disease (PD). However, the activity of lysosomal enzymes is heterogeneously observed in PD. We investigated whether arylsulfatase A (ARSA) level can be used as a fluid biomarker of PD and can reflect disease progression. Plasma ARSA level wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Han Soo, Lee, Jun Sung, Chung, Seok Jong, Ye, Byoung Seok, Sohn, Young H., Lee, Seung-Jae, Lee, Phil Hyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101326/
https://www.ncbi.nlm.nih.gov/pubmed/32221382
http://dx.doi.org/10.1038/s41598-020-62536-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101326/
https://www.ncbi.nlm.nih.gov/pubmed/32221382
http://dx.doi.org/10.1038/s41598-020-62536-4

Ejemplares similares